HCA Healthcare, Inc. filed a Form 8-K on November 2, 2026, disclosing that its wholly owned subsidiary HCA Inc. commenced a public offering of senior unsecured notes and issued notice of its intent to redeem all $1.200 billion of its outstanding 4.500% senior notes due February 2027.

Key Highlights

  • New offering announced: HCA Inc., a direct, wholly owned subsidiary of HCA Healthcare, Inc., commenced a proposed public offering of senior unsecured notes on November 2, 2026.
  • Redemption notice issued: HCA Inc. provided notice of its election to redeem all $1.200 billion of its 4.500% senior notes due February 2027.
  • Redemption date set: The redeemed notes are scheduled to be called on December 2, 2026.
  • Proceeds condition: The redemption is conditioned upon HCA Inc. receiving net proceeds from the new offering prior to the December 2, 2026 redemption date.
  • Exchange listing: HCA Healthcare common stock trades on the New York Stock Exchange under the symbol HCA (NYSE:HCA).

HCA Inc. Debt Refinancing: New Notes Offering Tied to February 2027 Note Redemption

According to the filing, HCA Healthcare, Inc. (NYSE:HCA) disclosed through an Item 8.01 Other Events report that its direct, wholly owned subsidiary, HCA Inc., announced the commencement of a proposed public offering of senior unsecured notes on November 2, 2026. The press release announcing the offering was attached as Exhibit 99.1 and incorporated by reference into the filing.

The filing further disclosed that on the same date, HCA Inc. provided notice of its election to redeem all $1.200 billion aggregate principal amount of its 4.500% senior notes due February 2027. The registrant identified those as the "Redeemed Notes" and set December 2, 2026 as the "Redemption Date." The redemption is conditioned upon HCA Inc. receiving the net proceeds from the new offering before that date. The filing stated that "the redemption of the Redeemed Notes is being made pursuant to a separately issued notice of redemption" and explicitly noted that the Form 8-K "does not constitute a notice of redemption of the Redeemed Notes."

The filing contains forward-looking statements, including references to the expected use of proceeds from the offering. The registrant noted that such statements "are not guarantees of future performance" and are subject to risks and uncertainties described in the company's Annual Report on Form 10-K filed February 10, 2026, and other regulatory filings. The filing was signed by John M. Franck II, Vice President - Legal and Corporate Secretary of HCA Healthcare, Inc.

What Was Disclosed

HCA Healthcare's 8-K filed November 2, 2026 reported that subsidiary HCA Inc. launched a senior unsecured notes offering and simultaneously issued notice to redeem all $1.200 billion of its 4.500% senior notes due February 2027, with a scheduled redemption date of December 2, 2026.